Marrone Bio Innovations Inc (MBII) 9.99 $MBII
Marrone Bio Innovations Submits VENERATE(TM) Bioinsecticide for Registration in Canada and Mexico
GlobeNewswire - Thu May 08, 9:05AM CDT
Marrone Bio Innovations, Inc. (MBI), (Nasdaq:MBII), a leading global provider of bio-based pest management and plant health products announced its VENERATE(TM) Bioinsecticide has been submitted for registration in Canada and Mexico. The new, broad-spectrum bioinsecticide is active against a wide array of chewing and sucking insects and mites and features novel modes of action that stem from a diverse set of natural compounds produced by a newly discovered bacterium.
Marrone Bio Innovations to Announce First Quarter 2014 Financial Results, May 13, 2014
GlobeNewswire - Mon May 05, 8:41AM CDT
Marrone Bio Innovations, Inc. (Nasdaq:MBII), a provider of bio-based pest management and plant health products for the agricultural and water treatment markets, announced today that the company will host a conference call and webcast on Tuesday, May 13, 2014, at 4:30pm Eastern Time to discuss its quarterly financial results for the period ended March 31, 2014. The call and webcast will follow the release of first quarter financial results after the market closes. The live webcast can be accessed on the Marrone Bio Innovations investor relations website at investors.marronebio.com, and a recorded version of the call will also be available on the website approximately one hour after the call.
Marrone Bio Innovations Launches VENERATE(TM) Broad-Spectrum Bioinsecticide
GlobeNewswire - Tue Apr 29, 9:29AM CDT
VENERATE(TM) Bioinsecticide is a new tool to help growers control crop-damaging insect pests, fight the development of insect resistance, and reduce pesticide residues on fruits and vegetables. Marrone Bio Innovations, Inc. (MBI), (Nasdaq:MBII), the maker of VENERATE, announced the product is now available in time for the 2014 growing season.
Marrone Bio Innovations to Present at Baird 2014 Growth Stock Conference
GlobeNewswire - Mon Apr 28, 10:05AM CDT
Marrone Bio Innovations, Inc. (Nasdaq:MBII), a leading global provider of bio-based pest management and plant health products for the agricultural and water treatment markets, announced today that Pam Marrone, Chief Executive Officer will present at the Baird Growth Stock Conference on Thursday, May 8 at the Four Seasons Hotel in Chicago, IL.
Marrone Bio Innovations announces registration submission of GRANDEVO in Mexico
M2 - Fri Apr 18, 6:26AM CDT
Plant health company Marrone Bio Innovations (NasdaqGM:MBII) revealed on Thursday the submission of GRANDEVO bioinsecticide for registration in Mexico.
Marrone Bio Innovations Submits Grandevo Bioinsecticide for Mexican Registration
GlobeNewswire - Thu Apr 17, 8:14AM CDT
Marrone Bio Innovations, Inc. (MBI) (Nasdaq:MBII), a leading global provider of bio-based pest management and plant health products announced it has submitted GRANDEVO bioinsecticide for registration in Mexico. GRANDEVO controls a broad spectrum of insects and mites in a wide variety of agricultural crops. Upon registration, it will join REGALIA MAXX biofungicide, the first MBI product registered in Mexico, in providing growers a high level of crop protection with the benefits of a bio-based product.
Marrone Bio Innovations submits the MBI-601 EP biofumigant for US EPA registration
M2 - Mon Apr 14, 7:58AM CDT
Plant health company Marrone Bio Innovations (NasdaqGM:MBII) disclosed on Friday that it has filed for US Environmental Protection Agency's (EPA) registration for its biofumigant, MBI-601 EP.
Marrone Bio Innovations Submits Biofumigant for EPA Registration
GlobeNewswire - Fri Apr 11, 9:00AM CDT
Marrone Bio Innovations, Inc. (MBI) (Nasdaq:MBII), a leading global provider of bio-based pest management and plant health products announced it has submitted MBI-601 EP, a biofumigant, to the United States Environmental Protection Agency (EPA) for registration. The product controls and suppresses plant parasitic nematodes, insect pests and soil-borne plant diseases in agricultural and horticultural soils. The active ingredient, Muscodor albus strain SA 13, produces volatile compounds that inhibit the growth of or kill economically important pests and plant diseases. It targets the most destructive species of nematodes--root knot, sting, ring, spiral, cyst, lance, and lesion and also the highly-damaging plant diseases Fusarium root rot, damping off, southern blight and Verticillium wilt. With this control, field trials show increased yields in treated strawberries, lettuce and other crops.
Biopesticide Companies Host EPA Officials on Local Farm Tour
GlobeNewswire - Mon Apr 07, 10:29AM CDT
The Biopesticide Industry Alliance (BPIA) and Sacramento-area biopesticide companies Marrone Bio Innovations (MBI) and Bayer Crop Science (BCS) are hosting laboratory visits and farm tour for EPA officials as part of the BPIA semi-annual meeting. The group will visit Sacramento Valley farmers who use biopesticides in an integrated pest management (IPM) approach on their farms to protect crops from disease and insect damage. The farm tour will be followed by tours of the MBI labs and the BCS facility, both in Davis.
Marrone Bio Innovations' REGALIA MAXX Biofungicide passes registration in Peru, helping boost table grapes exports to the US and Europe
M2 - Tue Apr 01, 4:14AM CDT
Plant health company Marrone Bio Innovations (NasdaqGM:MBII) on Monday declared REGALIA MAXX Biofungicide's product registration in Peru.
REGALIA(R) MAXX Biofungicide Receives Registration in Peru
GlobeNewswire - Mon Mar 31, 9:27AM CDT
Marrone Bio Innovations, Inc. (MBI) (Nasdaq:MBII), a leading global provider of bio-based pest management and plant health products, announced FMC, the exclusive Latin America distributor for its REGALIA MAXX Biofungicide, has received a product registration in Peru. Peru now joins El Salvador, Guatemala, Honduras, Panama and Mexico as Latin America countries having approved the use of REGALIA MAXX to control a wide variety of bacterial and fungal diseases across an array of agricultural crops.
Marrone Bio Innovations Hires VP of Technology Development
GlobeNewswire - Wed Mar 26, 8:00AM CDT
Marrone Bio Innovations, Inc. (MBI) (Nasdaq:MBII), a leading global provider of bio-based pest management and plant health products announced it has hired Amit Vasavada, Ph.D., as Vice President of Technology Development, a newly created position within the company. Dr. Vasavada brings 30 years of experience in industrial bioproducts, fermentation R&D and manufacturing, process engineering, and technology transfer to MBI. His broad commercial background includes positions with General Atomics, Vical Inc., Diversa Corporation, Monsanto (CP Kelco), and Chiron Corp.
Marrone Bio Innovations appoints Linda V. Moore as general counsel
M2 - Thu Mar 20, 6:00AM CDT
Plant health products Marrone Bio Innovations (NasdaqGM:MBII) said on Wednesday that Linda V. Moore has been elected to the newly created general counsel position.
Photo Release -- Marrone Bio Innovations Hires General Counsel
GlobeNewswire - Wed Mar 19, 9:00AM CDT
Marrone Bio Innovations, Inc. (MBI) (Nasdaq:MBII), a leading global provider of bio-based pest management and plant health products, announced it has hired Linda V. Moore in the newly created general counsel position. She previously served as General Counsel and Chief Compliance Officer for Merix Corp., Phoenix Technologies, and Jabil Circuit, in addition to being co-founder and principal of The Moore Group. Moore brings extensive experience in the areas of intellectual property, securities regulations and compliance, corporate governance, labor relations, and litigation management. She also has managed international tax, labor, and facilities issues with expatriate and extended assignments in Europe, Asia and Latin America.
Marrone Bio Innovations Receives Patent Surrounding Regalia(R) Biofungicide
GlobeNewswire - Mon Mar 10, 9:01AM CDT
Marrone Bio Innovations, Inc. (MBI) (Nasdaq:MBII), a leading global provider of bio-based pest management and plant health products announced it has received a United States patent covering applications of products containing anthraquinone derivatives, such as the company's flagship product Regalia Biofungicide. The issued claims cover methods for increasing plant growth, root initiation and extension when plant roots are treated with an anthraquinone derivative. The new patent protects uses of Regalia and any future MBI products containing these active ingredients.
Marrone Bio Innovations Reports Record Fourth Quarter and Fiscal Year 2013 Financial Results
GlobeNewswire - Fri Mar 07, 2:59AM CST
-- Full year 2013 revenue more than doubles to $14.5 million
Marrone Bio Innovations wins EPA registration for Venerate Bioinsecticide under its biological pest control portfolio
M2 - Tue Mar 04, 6:51AM CST
Plant health company Marrone Bio Innovations (NasdaqGM:MBII) disclosed on Monday the receipt of federal registration for its Venerate Bioinsecticide from the EPA.
Marrone Bio Innovations Receives EPA Registration for Venerate(TM) Bioinsecticide
GlobeNewswire - Mon Mar 03, 10:00AM CST
Marrone Bio Innovations, Inc. (MBI) (Nasdaq:MBII), a leading global provider of bio-based pest management and plant health products announced today its Venerate(TM) Bioinsecticide has received federal registration from the EPA. The insecticide controls a broad spectrum of pests and will be sold into a wide variety of crop segments.
Marrone Bio Innovations to Present at 26th Annual ROTH Conference
GlobeNewswire - Thu Feb 27, 9:00AM CST
Marrone Bio Innovations, Inc. (Nasdaq:MBII), a provider of bio-based pest management and plant health products for the agricultural and water treatment markets, announced today that Pam Marrone, Chief Executive Officer will present at the 26 Annual ROTH Conference on Tuesday March 11, 2014, Track 3, Salon 3 at the Ritz-Carlton Hotel in Dana Point, CA.
Marrone Bio Innovations Appoints New Chief Financial Officer
GlobeNewswire - Tue Feb 25, 5:00AM CST
Marrone Bio Innovations, Inc. (MBI) (Nasdaq:MBII), a leading global provider of bio-based pest management and plant health products, announced today it has hired James B. Boyd as Vice President and Chief Financial Officer (CFO). Mr. Boyd brings over thirty years of financial management experience spanning a variety of industries and companies ranging from Fortune 100 firms to start-ups and covering all aspects of the financial function including SEC reporting, GAAP compliance, SOX and internal controls, planning and budgeting as well as broad experience in debt, equity and M&A transactions.
Marrone Bio Innovations Submits VENERATE(TM) Bioinsecticide for Registration in Canada and Mexico
GlobeNewswire - Thu May 08, 9:05AM CDT
Marrone Bio Innovations, Inc. (MBI), (Nasdaq:MBII), a leading global provider of bio-based pest management and plant health products announced its VENERATE(TM) Bioinsecticide has been submitted for registration in Canada and Mexico. The new, broad-spectrum bioinsecticide is active against a wide array of chewing and sucking insects and mites and features novel modes of action that stem from a diverse set of natural compounds produced by a newly discovered bacterium.
Marrone Bio Innovations to Announce First Quarter 2014 Financial Results, May 13, 2014
GlobeNewswire - Mon May 05, 8:41AM CDT
Marrone Bio Innovations, Inc. (Nasdaq:MBII), a provider of bio-based pest management and plant health products for the agricultural and water treatment markets, announced today that the company will host a conference call and webcast on Tuesday, May 13, 2014, at 4:30pm Eastern Time to discuss its quarterly financial results for the period ended March 31, 2014. The call and webcast will follow the release of first quarter financial results after the market closes. The live webcast can be accessed on the Marrone Bio Innovations investor relations website at investors.marronebio.com, and a recorded version of the call will also be available on the website approximately one hour after the call.
Marrone Bio Innovations Launches VENERATE(TM) Broad-Spectrum Bioinsecticide
GlobeNewswire - Tue Apr 29, 9:29AM CDT
VENERATE(TM) Bioinsecticide is a new tool to help growers control crop-damaging insect pests, fight the development of insect resistance, and reduce pesticide residues on fruits and vegetables. Marrone Bio Innovations, Inc. (MBI), (Nasdaq:MBII), the maker of VENERATE, announced the product is now available in time for the 2014 growing season.
Marrone Bio Innovations to Present at Baird 2014 Growth Stock Conference
GlobeNewswire - Mon Apr 28, 10:05AM CDT
Marrone Bio Innovations, Inc. (Nasdaq:MBII), a leading global provider of bio-based pest management and plant health products for the agricultural and water treatment markets, announced today that Pam Marrone, Chief Executive Officer will present at the Baird Growth Stock Conference on Thursday, May 8 at the Four Seasons Hotel in Chicago, IL.
Marrone Bio Innovations announces registration submission of GRANDEVO in Mexico
M2 - Fri Apr 18, 6:26AM CDT
Plant health company Marrone Bio Innovations (NasdaqGM:MBII) revealed on Thursday the submission of GRANDEVO bioinsecticide for registration in Mexico.
Marrone Bio Innovations Submits Grandevo Bioinsecticide for Mexican Registration
GlobeNewswire - Thu Apr 17, 8:14AM CDT
Marrone Bio Innovations, Inc. (MBI) (Nasdaq:MBII), a leading global provider of bio-based pest management and plant health products announced it has submitted GRANDEVO bioinsecticide for registration in Mexico. GRANDEVO controls a broad spectrum of insects and mites in a wide variety of agricultural crops. Upon registration, it will join REGALIA MAXX biofungicide, the first MBI product registered in Mexico, in providing growers a high level of crop protection with the benefits of a bio-based product.
Marrone Bio Innovations submits the MBI-601 EP biofumigant for US EPA registration
M2 - Mon Apr 14, 7:58AM CDT
Plant health company Marrone Bio Innovations (NasdaqGM:MBII) disclosed on Friday that it has filed for US Environmental Protection Agency's (EPA) registration for its biofumigant, MBI-601 EP.
Marrone Bio Innovations Submits Biofumigant for EPA Registration
GlobeNewswire - Fri Apr 11, 9:00AM CDT
Marrone Bio Innovations, Inc. (MBI) (Nasdaq:MBII), a leading global provider of bio-based pest management and plant health products announced it has submitted MBI-601 EP, a biofumigant, to the United States Environmental Protection Agency (EPA) for registration. The product controls and suppresses plant parasitic nematodes, insect pests and soil-borne plant diseases in agricultural and horticultural soils. The active ingredient, Muscodor albus strain SA 13, produces volatile compounds that inhibit the growth of or kill economically important pests and plant diseases. It targets the most destructive species of nematodes--root knot, sting, ring, spiral, cyst, lance, and lesion and also the highly-damaging plant diseases Fusarium root rot, damping off, southern blight and Verticillium wilt. With this control, field trials show increased yields in treated strawberries, lettuce and other crops.
Biopesticide Companies Host EPA Officials on Local Farm Tour
GlobeNewswire - Mon Apr 07, 10:29AM CDT
The Biopesticide Industry Alliance (BPIA) and Sacramento-area biopesticide companies Marrone Bio Innovations (MBI) and Bayer Crop Science (BCS) are hosting laboratory visits and farm tour for EPA officials as part of the BPIA semi-annual meeting. The group will visit Sacramento Valley farmers who use biopesticides in an integrated pest management (IPM) approach on their farms to protect crops from disease and insect damage. The farm tour will be followed by tours of the MBI labs and the BCS facility, both in Davis.
Marrone Bio Innovations' REGALIA MAXX Biofungicide passes registration in Peru, helping boost table grapes exports to the US and Europe
M2 - Tue Apr 01, 4:14AM CDT
Plant health company Marrone Bio Innovations (NasdaqGM:MBII) on Monday declared REGALIA MAXX Biofungicide's product registration in Peru.
REGALIA(R) MAXX Biofungicide Receives Registration in Peru
GlobeNewswire - Mon Mar 31, 9:27AM CDT
Marrone Bio Innovations, Inc. (MBI) (Nasdaq:MBII), a leading global provider of bio-based pest management and plant health products, announced FMC, the exclusive Latin America distributor for its REGALIA MAXX Biofungicide, has received a product registration in Peru. Peru now joins El Salvador, Guatemala, Honduras, Panama and Mexico as Latin America countries having approved the use of REGALIA MAXX to control a wide variety of bacterial and fungal diseases across an array of agricultural crops.
Marrone Bio Innovations Hires VP of Technology Development
GlobeNewswire - Wed Mar 26, 8:00AM CDT
Marrone Bio Innovations, Inc. (MBI) (Nasdaq:MBII), a leading global provider of bio-based pest management and plant health products announced it has hired Amit Vasavada, Ph.D., as Vice President of Technology Development, a newly created position within the company. Dr. Vasavada brings 30 years of experience in industrial bioproducts, fermentation R&D and manufacturing, process engineering, and technology transfer to MBI. His broad commercial background includes positions with General Atomics, Vical Inc., Diversa Corporation, Monsanto (CP Kelco), and Chiron Corp.
Marrone Bio Innovations appoints Linda V. Moore as general counsel
M2 - Thu Mar 20, 6:00AM CDT
Plant health products Marrone Bio Innovations (NasdaqGM:MBII) said on Wednesday that Linda V. Moore has been elected to the newly created general counsel position.
Photo Release -- Marrone Bio Innovations Hires General Counsel
GlobeNewswire - Wed Mar 19, 9:00AM CDT
Marrone Bio Innovations, Inc. (MBI) (Nasdaq:MBII), a leading global provider of bio-based pest management and plant health products, announced it has hired Linda V. Moore in the newly created general counsel position. She previously served as General Counsel and Chief Compliance Officer for Merix Corp., Phoenix Technologies, and Jabil Circuit, in addition to being co-founder and principal of The Moore Group. Moore brings extensive experience in the areas of intellectual property, securities regulations and compliance, corporate governance, labor relations, and litigation management. She also has managed international tax, labor, and facilities issues with expatriate and extended assignments in Europe, Asia and Latin America.
Marrone Bio Innovations Receives Patent Surrounding Regalia(R) Biofungicide
GlobeNewswire - Mon Mar 10, 9:01AM CDT
Marrone Bio Innovations, Inc. (MBI) (Nasdaq:MBII), a leading global provider of bio-based pest management and plant health products announced it has received a United States patent covering applications of products containing anthraquinone derivatives, such as the company's flagship product Regalia Biofungicide. The issued claims cover methods for increasing plant growth, root initiation and extension when plant roots are treated with an anthraquinone derivative. The new patent protects uses of Regalia and any future MBI products containing these active ingredients.
Marrone Bio Innovations Reports Record Fourth Quarter and Fiscal Year 2013 Financial Results
GlobeNewswire - Fri Mar 07, 2:59AM CST
-- Full year 2013 revenue more than doubles to $14.5 million
Marrone Bio Innovations wins EPA registration for Venerate Bioinsecticide under its biological pest control portfolio
M2 - Tue Mar 04, 6:51AM CST
Plant health company Marrone Bio Innovations (NasdaqGM:MBII) disclosed on Monday the receipt of federal registration for its Venerate Bioinsecticide from the EPA.
Marrone Bio Innovations Receives EPA Registration for Venerate(TM) Bioinsecticide
GlobeNewswire - Mon Mar 03, 10:00AM CST
Marrone Bio Innovations, Inc. (MBI) (Nasdaq:MBII), a leading global provider of bio-based pest management and plant health products announced today its Venerate(TM) Bioinsecticide has received federal registration from the EPA. The insecticide controls a broad spectrum of pests and will be sold into a wide variety of crop segments.
Marrone Bio Innovations to Present at 26th Annual ROTH Conference
GlobeNewswire - Thu Feb 27, 9:00AM CST
Marrone Bio Innovations, Inc. (Nasdaq:MBII), a provider of bio-based pest management and plant health products for the agricultural and water treatment markets, announced today that Pam Marrone, Chief Executive Officer will present at the 26 Annual ROTH Conference on Tuesday March 11, 2014, Track 3, Salon 3 at the Ritz-Carlton Hotel in Dana Point, CA.
Marrone Bio Innovations Appoints New Chief Financial Officer
GlobeNewswire - Tue Feb 25, 5:00AM CST
Marrone Bio Innovations, Inc. (MBI) (Nasdaq:MBII), a leading global provider of bio-based pest management and plant health products, announced today it has hired James B. Boyd as Vice President and Chief Financial Officer (CFO). Mr. Boyd brings over thirty years of financial management experience spanning a variety of industries and companies ranging from Fortune 100 firms to start-ups and covering all aspects of the financial function including SEC reporting, GAAP compliance, SOX and internal controls, planning and budgeting as well as broad experience in debt, equity and M&A transactions.
